HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Enforcement, Earnings, Employment: Health And Wellness Industry News

This article was originally published in The Rose Sheet

Executive Summary

Prison sentence in DMAA supplement case; Abbott Nutrition flat on currency exchange; Lurie takes CSPI helm; and more news in brief.

You may also be interested in...



Wellness Market News: Vitamin Shoppe Loyalty Program Relaunch, Used At-Home Test Strips On Market, More

More ED-spiked coffee recalled; used, unapproved at-home tests on market; trade group unity in "Day On The Hill"; and Bronze, Silver, Gold Healthy Awards At Vitamin Shoppe.

FTC Settles With Supplement Marketer In Prison From FDA Investigation

FTC has settlement with CellMark and CEO Derek Vest alleging advertising regulation violations in marketing CellAssure supplements to treat cancer-related malnutrition, at $248 for a month's supply, and Cognify for treatment-related cognitive dysfunction sold for $79.

S.K. Labs VP Imprisoned Before Trial On Charges Linked To USPlabs

S.K. Labs VP Sitesh Patel was sentenced for his conviction in an April trial of single counts of conspiracy to defraud FDA and conspiracy to commit mail fraud and three counts of mail fraud. He faced up to 85 years in prison and up to $1.25m in fines.

Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS121089

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel